A Multicenter, RAndomIzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With AI-assisted Robotic guidanCe for Hemorrhagic Stroke

Participants must meet all of the following inclusion criteria: 1. Age ≥18 years at randomization； 2. Diagnosed with brainstem hemorrhage via imaging (CT, CTA, etc.)； 3. Hematoma volume ≥3 mL； 4. Glasgow Coma Scale (GCS) score of 3-12； 5. Available for surgery within 48 hours after onset； 6. Modified Rankin Scale (mRS) score ≤ 1 prior to this hemorrhage； 7. Informed consent obtained in accordance with national laws, regulations, and applicable ethics committee requirements. Patients will be excluded if they meet any of the following criteria: 1. Hematoma involving other regions such as the supratentorial compartment, basal ganglia, thalamus, midbrain, or ventricles. 2. Radiologically confirmed cerebral vascular abnormalities including ruptured aneurysms, arteriovenous malformations (AVMs), or Moyamoya disease; hemorrhagic transformation of ischemic infarcts; or recent (within 1 year) recurrence of intracerebral hemorrhage； 3. Any irreversible coagulation disorder or known coagulopathy; platelet count \<100,000/µL; INR \>1.4; or use of anticoagulant medication within 7 days before the current hemorrhage； 4. Current or probable pregnancy； 5. Patients with concurrent severe illness likely to influence outcome assessment； 6. Difficulty in follow-up or poor compliance due to any cause.